| UniProt ID | 1433F_HUMAN | |
|---|---|---|
| UniProt AC | Q04917 | |
| Protein Name | 14-3-3 protein eta | |
| Gene Name | YWHAH | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 246 | |
| Subcellular Localization | ||
| Protein Description | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negatively regulates the kinase activity of PDPK1.. | |
| Protein Sequence | MGDREQLLQRARLAEQAERYDDMASAMKAVTELNEPLSNEDRNLLSVAYKNVVGARRSSWRVISSIEQKTMADGNEKKLEKVKAYREKIEKELETVCNDVLSLLDKFLIKNCNDFQYESKVFYLKMKGDYYRYLAEVASGEKKNSVVEASEAAYKEAFEISKEQMQPTHPIRLGLALNFSVFYYEIQNAPEQACLLAKQAFDDAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDQQDEEAGEGN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MGDREQLLQ ------CCHHHHHHH | 42.56 | - | |
| 20 | Phosphorylation | LAEQAERYDDMASAM HHHHHHHHHHHHHHH | 14.06 | 20068231 | |
| 25 | Phosphorylation | ERYDDMASAMKAVTE HHHHHHHHHHHHHHH | 23.43 | 20068231 | |
| 38 | Phosphorylation | TELNEPLSNEDRNLL HHHCCCCCHHHCCHH | 49.22 | 46155625 | |
| 42 | Methylation | EPLSNEDRNLLSVAY CCCCHHHCCHHHHHH | 29.53 | - | |
| 46 | Phosphorylation | NEDRNLLSVAYKNVV HHHCCHHHHHHHHHH | 14.10 | 19664994 | |
| 49 | Phosphorylation | RNLLSVAYKNVVGAR CCHHHHHHHHHHCCC | 10.84 | 22617229 | |
| 50 | Acetylation | NLLSVAYKNVVGARR CHHHHHHHHHHCCCC | 33.26 | 129327 | |
| 50 | Ubiquitination | NLLSVAYKNVVGARR CHHHHHHHHHHCCCC | 33.26 | 21906983 | |
| 50 | Methylation | NLLSVAYKNVVGARR CHHHHHHHHHHCCCC | 33.26 | - | |
| 58 | Phosphorylation | NVVGARRSSWRVISS HHHCCCCCCCHHHHH | 28.79 | 23882029 | |
| 59 | Phosphorylation | VVGARRSSWRVISSI HHCCCCCCCHHHHHH | 19.65 | 7785495 | |
| 64 | Phosphorylation | RSSWRVISSIEQKTM CCCCHHHHHHHHHHC | 23.54 | 27273156 | |
| 65 | Phosphorylation | SSWRVISSIEQKTMA CCCHHHHHHHHHHCC | 21.01 | 23911959 | |
| 69 | Malonylation | VISSIEQKTMADGNE HHHHHHHHHCCCCCH | 27.72 | 26320211 | |
| 69 | Ubiquitination | VISSIEQKTMADGNE HHHHHHHHHCCCCCH | 27.72 | 21890473 | |
| 69 | Acetylation | VISSIEQKTMADGNE HHHHHHHHHCCCCCH | 27.72 | 23954790 | |
| 69 | Succinylation | VISSIEQKTMADGNE HHHHHHHHHCCCCCH | 27.72 | 23954790 | |
| 77 | Ubiquitination | TMADGNEKKLEKVKA HCCCCCHHHHHHHHH | 67.66 | 21906983 | |
| 91 | Ubiquitination | AYREKIEKELETVCN HHHHHHHHHHHHHHH | 71.69 | - | |
| 106 | Ubiquitination | DVLSLLDKFLIKNCN HHHHHHHHHHHHCCC | 41.88 | - | |
| 110 | Acetylation | LLDKFLIKNCNDFQY HHHHHHHHCCCCCCE | 58.56 | 26051181 | |
| 110 | Ubiquitination | LLDKFLIKNCNDFQY HHHHHHHHCCCCCCE | 58.56 | 21890473 | |
| 117 | Phosphorylation | KNCNDFQYESKVFYL HCCCCCCEEECEEEE | 23.36 | 28152594 | |
| 119 | Phosphorylation | CNDFQYESKVFYLKM CCCCCEEECEEEEEE | 29.23 | 28152594 | |
| 120 | Ubiquitination | NDFQYESKVFYLKMK CCCCEEECEEEEEEC | 25.15 | - | |
| 120 | Acetylation | NDFQYESKVFYLKMK CCCCEEECEEEEEEC | 25.15 | 26051181 | |
| 123 | Phosphorylation | QYESKVFYLKMKGDY CEEECEEEEEECCHH | 14.38 | 7101457 | |
| 125 | Acetylation | ESKVFYLKMKGDYYR EECEEEEEECCHHHH | 27.47 | 7298949 | |
| 125 | Ubiquitination | ESKVFYLKMKGDYYR EECEEEEEECCHHHH | 27.47 | 21906983 | |
| 127 | Ubiquitination | KVFYLKMKGDYYRYL CEEEEEECCHHHHHH | 47.22 | 21906983 | |
| 130 | Phosphorylation | YLKMKGDYYRYLAEV EEEECCHHHHHHHHH | 9.86 | 28152594 | |
| 131 | Phosphorylation | LKMKGDYYRYLAEVA EEECCHHHHHHHHHH | 9.49 | 28152594 | |
| 133 | Phosphorylation | MKGDYYRYLAEVASG ECCHHHHHHHHHHCC | 8.31 | 28152594 | |
| 139 | Phosphorylation | RYLAEVASGEKKNSV HHHHHHHCCCCCCCH | 53.30 | 110748691 | |
| 142 | Ubiquitination | AEVASGEKKNSVVEA HHHHCCCCCCCHHHH | 61.86 | 21906983 | |
| 142 | Acetylation | AEVASGEKKNSVVEA HHHHCCCCCCCHHHH | 61.86 | 25953088 | |
| 143 | Ubiquitination | EVASGEKKNSVVEAS HHHCCCCCCCHHHHH | 50.59 | - | |
| 145 | Phosphorylation | ASGEKKNSVVEASEA HCCCCCCCHHHHHHH | 36.10 | 20873877 | |
| 154 | Phosphorylation | VEASEAAYKEAFEIS HHHHHHHHHHHHHCC | 19.19 | 110748699 | |
| 155 | Ubiquitination | EASEAAYKEAFEISK HHHHHHHHHHHHCCH | 37.53 | - | |
| 162 | Ubiquitination | KEAFEISKEQMQPTH HHHHHCCHHHCCCCC | 58.59 | 21890473 | |
| 165 | Sulfoxidation | FEISKEQMQPTHPIR HHCCHHHCCCCCCCC | 5.59 | 30846556 | |
| 168 | Phosphorylation | SKEQMQPTHPIRLGL CHHHCCCCCCCCHHH | 24.32 | 20068231 | |
| 210 | Phosphorylation | DAIAELDTLNEDSYK HHHHHHHCCCCCCCC | 44.07 | 110747425 | |
| 215 | Phosphorylation | LDTLNEDSYKDSTLI HHCCCCCCCCCHHHH | 28.09 | 20068231 | |
| 216 | Phosphorylation | DTLNEDSYKDSTLIM HCCCCCCCCCHHHHH | 31.01 | 119397 | |
| 219 | Phosphorylation | NEDSYKDSTLIMQLL CCCCCCCHHHHHHHH | 22.44 | 25850435 | |
| 220 | Phosphorylation | EDSYKDSTLIMQLLR CCCCCCHHHHHHHHH | 30.36 | 19664994 | |
| 223 | Sulfoxidation | YKDSTLIMQLLRDNL CCCHHHHHHHHHHCC | 2.30 | 30846556 | |
| 234 | Phosphorylation | RDNLTLWTSDQQDEE HHCCEEEECCHHCHH | 26.07 | 24275569 | |
| 235 | Phosphorylation | DNLTLWTSDQQDEEA HCCEEEECCHHCHHC | 23.11 | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 59 | S | Phosphorylation | Kinase | PDK3 | Q15120 | GPS |
| 59 | S | Phosphorylation | Kinase | PDKC | - | PhosphoELM |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 59 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 1433F_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. | |